# Observational Hypertension, Portal studies: 41 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 41 trials that are observational for Hypertension, Portal that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Hypertension, Portal studies: 41 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/hypertension-portal

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 41
- Recruiting or not yet: 41
- Read on: November 19, 2026

## Trials

The 25 newest of 41, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 5, 2026 | NCT07918378 | Treatment Outcomes and Predictors After Endovascular Intervention for Portal Hypertension-Related Gastrointestinal Bleeding in Cirrhosis | University Medical Center Ho Chi Minh City (UMC) | Observational | Recruiting | Cirrhosis, Portal Hypertension Related to Cirrhosis, GI Bleeding, Gastrointestinal Bleeding | 167 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918378) |
| October 19, 2026 | NCT07880678 | Risk Stratification for Adverse Events in End-Stage Liver Disease | The Second Affiliated Hospital of Chongqing Medical University | Observational | Not yet recruiting | Decompensated Cirrhosis | 2,235 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880678) |
| October 16, 2026 | NCT07877298 | Within-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement | University Hospital Muenster | Observational | Not yet recruiting | Portal Hypertension, Chronic Liver Disease, Liver Cirrhosis | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877298) |
| October 16, 2026 | NCT07877272 | Endohepatology-Based Reclassification of Treatment Indication in High-Risk MASLD | University Hospital Muenster | Observational | Recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, Liver... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877272) |
| September 25, 2026 | NCT07842666 | Baveno VIII Criteria for Portal Hypertension in Egyptian Patients | Assiut University | Observational | Not yet recruiting | Compensated Liver Disease, Esophageal Varices, Portal Hypertension, Chronic Liver Disease | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842666) |
| May 20, 2026 | NCT07598669 | Austrian PBC Registry | Medical University of Vienna | Observational | Recruiting | Primary Biliary Cholangitis, Liver Cirrhosis, Portal Hypertension | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07598669) |
| May 14, 2026 | NCT07588373 | Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up) | Northern Jiangsu People's Hospital | Observational | Not yet recruiting | Cirrhosis, Splenectomy; Status, Hypersplenism, Lipid Profiles | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588373) |
| May 14, 2026 | NCT07588334 | Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up) | Northern Jiangsu People's Hospital | Observational | Not yet recruiting | Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension, Lipid Profiles | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588334) |
| May 14, 2026 | NCT07585786 | Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up) | Northern Jiangsu People's Hospital | Observational | Not yet recruiting | Cirrhosis, Liver, Splenectomy; Status, Renal Function Abnormal, Portal Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07585786) |
| May 14, 2026 | NCT07585773 | Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up) | Northern Jiangsu People's Hospital | Observational | Not yet recruiting | Cirrhosis, Splenectomy; Status, Hypersplenism, Kidney Function Issue | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07585773) |
| May 6, 2026 | NCT07571876 | Ultrasound Prediction of Esophageal Variceal Bleeding Risk | Assiut University | Observational | Not yet recruiting | Variceal Bleeding, Ultrasonography, Esophageal Bleeding, Esophageal Varices, Liver Cirrhosis, Portal Hypertension... | 165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07571876) |
| March 31, 2026 | NCT07502729 | Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding | Shanghai Zhongshan Hospital | Observational | Not yet recruiting | Portal Hypertension, Gastroesophageal Varices Hemorrhage, Gastric Varices, Esophageal Varices | 1,066 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502729) |
| March 19, 2026 | NCT07481877 | Portosystemic Shunt-associated Pulmonary Hypertension Multi-center Prospective Cohort Study | Chinese Pulmonary Vascular Disease Research Group | Observational | Not yet recruiting | Portosystemic Shunt, Pulmonary Hypertension | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07481877) |
| March 16, 2026 | NCT07473375 | Indicators Affecting PVT Recanalization | Shanghai Zhongshan Hospital | Observational | Recruiting | Portal Vein Thrombosis, Cirrhosis, Portal Hypertension Related to Cirrhosis, Portal Hypertension, Noncirrhotic | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07473375) |
| March 11, 2026 | NCT07464522 | Non-invasive Predictors of Esophageal Varices and Their Correlation to Upper Endoscopic Findings | Assiut University | Observational | Not yet recruiting | Esophageal Varices, Portal Hypertension | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07464522) |
| February 27, 2026 | NCT07439939 | Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Liver Cirrhosis, Portal Hypertension | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07439939) |
| February 19, 2026 | NCT07419724 | Construction of a Portal Hypertension Biobank | Shanghai Zhongshan Hospital | Observational | Recruiting | Variceal Bleeding, Portal Hypertension | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07419724) |
| February 12, 2026 | NCT07405749 | Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Cirrhosis, Liver, Portal Hypertension, Clinically Significant Portal Hypertension(CSPH), Gastroesophageal Varices | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07405749) |
| February 5, 2026 | NCT07390344 | VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS) | W.L.Gore & Associates | Observational | Recruiting | Ascites, Variceal Bleeding, Portal Hypertension Related to Cirrhosis | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390344) |
| January 22, 2026 | NCT07358663 | Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices | Shanghai Zhongshan Hospital | Observational | Recruiting | Esophagogastric Varices, Portal Hypertension | 1,384 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07358663) |
| December 12, 2025 | NCT07280390 | Microplastics, Cirrhosis and Portal Hypertension | Post Graduate Institute of Medical Education and Research, Chandigarh | Observational | Recruiting | Cirrhosis, Microplastics, Portal Hypertension Related to Cirrhosis, Nanoplastics, Pollution, Cirrhosis and Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07280390) |
| September 9, 2025 | NCT07163689 | TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease | Centre Hospitalier Universitaire, Amiens | Observational | Recruiting | TIPS, Portal Hypertension, Porto-Sinusoidal Vascular Disease, Refractory Ascite, Esophageal Varices, Gastrointestinal... | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07163689) |
| July 25, 2025 | NCT07087041 | A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests | Beijing Friendship Hospital | Observational | Not yet recruiting | Decompensated Cirrhosis, Hepatitis B Virus (HBV) Infection, Metabolic Dysfunction-Associated Steatotic Liver Disease... | 735 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07087041) |
| May 14, 2025 | NCT06970509 | Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension | Shanghai Zhongshan Hospital | Observational | Recruiting | Esophageal Varices, Portal Hypertension | 1,450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06970509) |
| November 19, 2024 | NCT06694090 | Von Willebrand Factor Levels in Patients With Liver Cirrhosis and Portal Hypertension | Assiut University | Observational | Not yet recruiting | Liver Cirrhosis, Portal Hypertension | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06694090) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Shanghai Zhongshan Hospital | 5 |
| Assiut University | 4 |
| Northern Jiangsu People's Hospital | 4 |
| University Hospital, Bonn | 2 |
| Medical University of Vienna | 2 |
| University Hospital Muenster | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Hannover Medical School | 1 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 1 |
| Shengjing Hospital | 1 |
| Karl Landsteiner University of Health Sciences | 1 |
| Chinese Pulmonary Vascular Disease Research Group | 1 |
| [W.L.Gore & Associates](https://specstream.ai/data/clinical-trials/company/w-l-gore-and-associates) | 1 |
| Chinese University of Hong Kong | 1 |
| The Second Affiliated Hospital of Chongqing Medical University | 1 |
| Beijing Friendship Hospital | 1 |
| Massachusetts General Hospital | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| University Hospital Freiburg | 1 |
| [Lifetech Scientific (Shenzhen) Co., Ltd.](https://specstream.ai/data/clinical-trials/company/lifetech-scientific-shenzhen-co-ltd) | 1 |
| Linkoeping University | 1 |
| University Medical Center Ho Chi Minh City (UMC) | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 12 |
| Germany | 7 |
| Italy | 5 |
| Austria | 4 |
| United States | 3 |
| France | 2 |
| India | 2 |
| Belgium | 1 |
| Canada | 1 |
| Australia | 1 |
| Hong Kong | 1 |
| Singapore | 1 |
| Turkey (Türkiye) | 1 |
| Sweden | 1 |
| Vietnam | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical products wholesalers in the United States](https://specstream.ai/data/businesses/pharmaceutical-products-wholesalers/united-states)
- [Electrical supply stores in the United States](https://specstream.ai/data/businesses/electrical-supply-stores/united-states)
- [Tree services in the United States](https://specstream.ai/data/businesses/tree-services/united-states)
- [Jamaican restaurants in the United States](https://specstream.ai/data/businesses/jamaican-restaurants/united-states)
- [Blinds and shades companies in the United States](https://specstream.ai/data/businesses/blinds-and-shades-companies/united-states)
- [Private schools in the United States](https://specstream.ai/data/businesses/private-schools/united-states)
